Discontinuation Of The Toxin - Toxicology

Relevant Publications

Compatible co-administration of BioThrax® vaccine and ciprofloxacin-Results of a randomized open-label drug-vaccine interaction trial.

Issue Release: 2024

Factors Associated With Onabotulinum Toxin-A Discontinuation in a Diverse Urban Population.

Issue Release: 2024

Long-Term Adherence to Onabotulinum Toxin-A Intradetrusor Injections for Neurogenic Dysfunction in Children-A Retrospective Single-Center Evaluation.

Issue Release: 2024

A randomized, active-controlled, multi-centric, phase-II clinical study to assess safety and immunogenicity of a fully liquid DTwP-HepB-IPV-Hib hexavalent vaccine (HEXASIIL®) in Indian toddlers.

Issue Release: 2024

Comparison of Treatment Patterns in Patients with Migraine Initiating Calcitonin Gene-Related Peptide Monoclonal Antibodies: A Retrospective Real-World US Study.

Issue Release: 2024

Effectiveness of 0.3% Hyaluronic Acid Eye Drops for Benign Essential Blepharospasm and Hemifacial Spasm with Botulinum Toxin-induced Dry Eye.

Issue Release: 2024

Efficacy, Satisfaction, and Compliance: Insights from 15 Years of Botulinum Toxin Use for Female Urgency Urinary Incontinence.

Issue Release: 2024

Recurrent acute kidney injury with Fanconi syndrome related to red yeast rice supplement.

Issue Release: 2024

Refractory occipital neuralgia treatment with nerve decompression surgery: a case series.

Issue Release: 2023

Predictors for adverse events following intravesical botulinum toxin injections in men.

Issue Release: 2023

Pooled Safety Analysis of IncobotulinumtoxinA in the Treatment of Neurological Disorders in Adults.

Issue Release: 2023

High anti-tumor activity of a novel alpha-fetoprotein-maytansinoid conjugate targeting alpha-fetoprotein receptors in colorectal cancer xenograft model.

Issue Release: 2023

Liver injury: the therapeutic dilemma of homeopathy - a case report from Bangladesh.

Issue Release: 2023

Ten open questions in migraine prophylaxis with monoclonal antibodies blocking the calcitonin-gene related peptide pathway: a narrative review.

Issue Release: 2023

Complement Blockade Is a Promising Therapeutic Approach in a Subset of Critically Ill Adult Patients with Complement-Mediated Hemolytic Uremic Syndromes.

Issue Release: 2022

Deterioration of bladder compliance after botulinum toxin A injection and discontinuation of medication for overactive bladder.

Issue Release: 2022

BT8009; a Nectin-4 targeting Bicycle® Toxin Conjugate for treatment of solid tumors.

Issue Release: 2022

Mirabegron in Overactive Bladder and Its Role in Exit Strategy After Botulinum Toxin Treatment in Children.

Issue Release: 2022

[Late-Onset Dyskinesia Occurring During Antipsychotic Treatment for Schizophrenia: Management of Tardive Dyskinesia Based on the Latest Knowledge].

Issue Release: 2022

Eculizumab for paediatric patients with atypical haemolytic-uremic syndrome: full dataset analysis of post-marketing surveillance in Japan.

Issue Release: 2022

What Are the Benefits of Continuing Education for Toxicologists?

How does the tear film act as a barrier to toxins?

How Does the Diet Relate to Toxicology?

What Are the Health Effects of Sodium Nitrate?

How Reliable Are Non-Invasive Methods?

What is the Role of WHO in Toxicology Under the UN?

What is Ketosis?

What are the Limitations of Using Stable Isotopes in Toxicology?

How Do Persistent Substances Affect Human Health?

How Do Medications and Substances Contribute to Insomnia?

Discontinuation Of The Toxin - Toxicology

Relevant Publications

Partnered Content Networks

Relevant Topics